Novavax’s Protein COVID-19 Vaccine Now Available in Europe
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]
Coronavirus Spreading Among the Vaccinated in Highly Vaccinated Countries
A recent study published by King’s College in London, which operates the ZOE COVID Study app to monitor COVID infection and vaccination rates, found that, as of July 15, 2021, there was an average of 15,537 new daily symptomatic cases of COVID-19 among partly or fully vaccinated people in the United Kingdom—an increase of 40 […]
